GENTIAN DIAGNOSTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45 NOK | -1.32% |
|
+7.66% | +8.43% |
| Apr. 30 | Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 30 | Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024 |
Evolution of the average Target Price on Gentian Diagnostics
Price target over the last 5 years
History of analyst recommendation changes
1790b6f7d6f1f65ebdcbaeb6b00.urmdUI1cuOHyrXoaKNOQONveM0bVcK1lUINX-nTkvHw.2-HKaP05i4mTwwJgXb__T5OpBTOyL_4sA7QhrxKTjwTw8ulm_j7XsLPqOw~912f4228d933af904c5adc8e65aaf8e4
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45
NOK
Average target price
57
NOK
Spread / Average Target
+26.67%
High Price Target
57
NOK
Spread / Highest target
+26.67%
Low Price Target
57
NOK
Spread / Lowest Target
+26.67%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- GENT Stock
- Consensus Gentian Diagnostics
